Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
38.79
+0.17 (0.44%)
At close: Jul 19, 2024, 4:00 PM
39.01
+0.22 (0.57%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
CALT Market Cap
CALT has a market cap or net worth of $1.04 billion as of July 22, 2024. Its market cap has increased by 121.34% in one year.
Market Cap
1.04B
Enterprise Value
1.04B
1-Year Change
121.34%
Ranking
Category
Stock Price
$38.79
Market Cap Chart
Since June 5, 2020, CALT's market cap has increased from $453.70M to $1.04B, an increase of 129.44%. That is a compound annual growth rate of 22.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.16B | 50.68% |
| Dec 29, 2023 | 766.90M | 52.65% |
| Dec 30, 2022 | 502.40M | -18.74% |
| Dec 31, 2021 | 618.30M | -20.55% |
| Dec 31, 2020 | 778.20M | 71.52% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innoviva | 1.07B |
| Ironwood Pharmaceuticals | 1.07B |
| Collegium Pharmaceutical | 1.06B |
| MiMedx Group | 1.06B |
| Cullinan Oncology | 1.05B |
| OPKO Health | 1.04B |
| Tyra Biosciences | 1.04B |
| Enliven Therapeutics | 1.04B |